UCB and Biogen’s dapirolizumab pegol paves path for systemic lupus erythematosus treatment
With a novel CD40L-targeting mechanism and favourable efficacy outcomes, this therapy has the potential to challenge established…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.